BDBM328756 (S)-1,1,1-trifluoro-2- methylpropan-2-yl (4-((3- chloro-4- fluorophenyl)sulfonyl)-2-((3- methyloxetane-3- carboxamido)methyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US9663502, 34Bi

SMILES CC(C)(OC(=O)Nc1ccc2O[C@@H](CNC(=O)C3(C)COC3)CN(c2c1)S(=O)(=O)c1ccc(F)c(Cl)c1)C(F)(F)F

InChI Key InChIKey=DJRGBPBRDVZLIO-HNNXBMFYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 328756   

TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Lycera

US Patent
LigandPNGBDBM328756((S)-1,1,1-trifluoro-2- methylpropan-2-yl (4-((3- c...)
Affinity DataIC50:  3.87nMAssay Description:The compounds of the invention inhibit RORgammaT activity. Activation of RORgammaT activity can be measured using, e.g., a biochemical TR-FRET assay....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent